Twin Lakes Capital Management’s GSK GSK Stock Holding History

Twin Lakes Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-957	Closed	-$32.4K	–	233
2024 Q4	$32.4K	Hold	957	–	–	0.02%	157
2024 Q3	$39.1K	Hold	957	–	–	0.03%	151
2024 Q2	$36.8K	Hold	957	–	–	0.03%	152
2024 Q1	$41K	Hold	957	–	–	0.03%	151
2023 Q4	$35.5K	Hold	957	–	–	0.02%	153
2023 Q3	$34.7K	Hold	957	–	–	0.03%	150
2023 Q2	$34.1K	Hold	957	–	–	0.02%	151
2023 Q1	$34K	Hold	957	–	–	0.03%	150
2022 Q4	$33.6K	Hold	957	–	–	0.03%	150
2022 Q3	$28K	Buy	957 +143	+18%	+$5.42K	0.02%	162
2022 Q2	$44K	Hold	814	–	–	0.03%	111
2022 Q1	$44K	Hold	814	–	–	0.02%	165
2021 Q4	$45K	Hold	814	–	–	0.02%	166
2021 Q3	$39K	Hold	814	–	–	0.02%	168
2021 Q2	$40K	Hold	814	–	–	0.02%	147
2021 Q1	$36K	Buy	+814	New	+$36.9K	0.02%	143

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Twin Lakes Capital Management's GSK Position: Q1 2025 in Review

Twin Lakes Capital Management sold out of GSK (GSK) in Q1 2025, closing a stake of 957 shares — an estimated $32.4K sold.

Twin Lakes Capital Management first reported a position in GSK in Q1 2021 and held it in 16 quarters. The position peaked at $45K in Q4 2021. 857 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

Twin Lakes Capital Management reported no remaining GSK position as of Q1 2025 after selling out during the quarter.
Twin Lakes Capital Management sold 957 GSK shares in Q1 2025, an estimated $32.4K.
Twin Lakes Capital Management first reported a position in GSK in Q1 2021 and held it in 16 quarters.
Twin Lakes Capital Management's GSK position peaked at $45K in Q4 2021.
857 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Twin Lakes Capital Management's 13F filing for Q1 2025, filed 23 May 2025.